While some describe improved energy and well-being, others note difficulty sleeping, particularly in the early weeks of treatment
The market is heading for a shake-up, however, as Novo Nordisk is heading for the loss of patent protection for its GLP-1 agonist semaglutide in China before the end of this month, which could be followed by the entry of lower-cost generic alternatives
DOI: 10.1080/14656566.2024.2343092 Vittone, J., et al
Improved Metabolic Health: By regulating both appetite and blood sugar, GLP-1 receptor agonists not only assist in weight loss but also help reduce the risk of diabetes-related complications
It also supports your nerves
Dosis recomendada Un rango habitual es 500 a 2,000 mg al da, repartido en una o dos tomas